ModuLight
Boston, Israel · Founded 2022 · $12.2M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- modulight.bio
- Total Funding
- $12.2M
- Last Round
- $12.2M SeedNov 2025
- Rounds
- 1
About
Revolutionising the treatment of severe neurological conditions
Summary
ModuLight is a Biotech company based in Boston, Israel, founded in 2022. It has raised $12.2M in total across 1 round, most recently a $12.2M Seed round in Nov 2025. Investors include Jib Ventures, LocalGlobe and Nexus NeuroTech Ventures.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2025
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Global contract research organization providing comprehensive drug development and laboratory ser...